Comparison of oral iron chelators in the management of transfusion-dependent β-thalassemia major based on serum ferritin and liver enzymes [version 2; peer review: 2 approved]
Background Excess iron deriving from a chronic transfusion and dietary intake increases the risk for cardiac complications in β-thalassemia major patients. Deferiprone and deferasirox are commonly prescribed to thalassemic patients who are at risk of iron overload. This study aimed to compare the pe...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2023-12-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | https://f1000research.com/articles/12-154/v2 |